Texas A&M, MD Anderson Scientists tested inhaled therapeutic to protect against COVID-19
On Jul. 9, 2020, scientists from Texas A&M University, biopharmaceutical company Pulmotect and MD Anderson Cancer Center announced they had begun testing a lung inhalent drug that could provide short-term immunity against COVID-19.
Tags:
Source: Texas A&M
Credit:
